王冠驊有20年以上的工藝開發(fā)和生產經驗。他曾任職于美國的新藥研發(fā)公司（KOSAN,基因泰克，和安進）以及國內CDMO公司（藥明生物和蘇橋）。他有豐富的一線生產、工藝研發(fā)和商業(yè)開發(fā)的經驗。最近幾年，他參與了多項GMP生物工廠的設計、建造和運營。
他目前在科望醫(yī)藥，一家致力于下一代腫瘤免疫治療的創(chuàng)新公司，擔任技術運營副總裁。，在此他能夠充分發(fā)揮自己的專長，為患者帶來救命藥物。
王冠驊2000年畢業(yè)于英屬不列顛哥倫比亞大學化工專業(yè)，2010年獲得南加州大學工商管理碩士學位。
Peter has over 20 years of Process Development and Manufacturing experience in the US and China with innovator companies (KOSAN, Genentech, and Amgen), as well as CDMOs (WuXi Biologics and CMAB). He has strong hands-on experience in manufacturing, process development, and business development.? Most recently, he supported the design, build, and operation of multiple GMP manufacturing facilities .
His current role as the VP of Technical Operations at Elpiscience Biopharma, a company focusing on the next generation of cancer immunotherapy, allows him to fully utilize his expertise to bring lifesaving drugs to patients.
Peter graduated from University of British Columbia, with the bachelor degree in Chemical Engineering in 2000 and obtained his M.B.A. from University of Southern California in 2010.